SII ships first set of malaria vaccine doses to Africa
- May 21, 2024
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
SII ships first set of malaria vaccine doses to Africa
Sub: Science and tech
Sec: Health
Context:
- Serum Institute of India (SII) marked a significant milestone on Monday with the shipment of the first set of R21/Matrix-M malaria vaccine to seven-eight countries in Africa.
More on news:
- Close to half-a-million children die of malaria each year in the African region, according to the World Health Organisation (WHO).
- SII has entered into a partnership with Novovax, University of Oxford and the United States government.
- 1,63,800 doses were allocated for the Central African Republic (CAR) region and 43,200 doses were dispatched from the SII facility.
- The initial shipment will be sent to CAR, followed by other African countries such as South Sudan and the Democratic Republic of Congo in the coming days.
What is Malaria?
- Malaria is a life threatening mosquito borne blood disease caused by plasmodium parasites.
- It is predominantly found in the tropical and subtropical areas of Africa, South America as well as Asia.
- The parasites spread through the bites of infected female Anopheles mosquitoes.
- After entering the human body, parasites initially multiply within the liver cells and then attack the Red Blood Cells (RBCs) resulting in their rupture.
- There are5 parasite species that cause malaria in humans, and 2 of these species – Plasmodium falciparum and Plasmodium vivax – pose the greatest threat.
- Symptoms of malaria include fever and flu-like illness, including shaking chills, headache, muscle aches, and tiredness.
- It is preventable as well as curable.
What is the R21/Matrix-M malaria vaccine?
- The low-cost, high-efficacy R21/Matrix-M malaria vaccine is developed by the University of Oxford and SII leveraging Novavax’s adjuvant technology.
- The vaccine has demonstrated high efficacy with a reassuring safety profile and the R21//Matrix-M vaccine is the second malaria vaccine to be authorized for use in children in malaria-endemic regions.
- On a vaccine for India, it was pointed out that the particular parasite (found in Africa) was not in India.
- It will take another five years for a malaria vaccine, for India.